arrow

department of internal medicine
H指数:0
被引数:173

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Glucagon-Like Peptide-2 (GLP-2) Analogues in Patients With Short Bowel Syndrome Dependent on Parenteral Support: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

胰高血糖素样肽-2(GLP-2)类似物在依赖肠外支持的短肠综合征患者中的应用:一项随机对照试验的系统评价和Meta分析

2025-12-200
OAAI
TNF antagonists withdrawal is not advised in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis of randomized controlled trials

对于炎症性肠病缓解期的患者,不推荐停用TNF拮抗剂:一项随机对照试验的系统评价和荟萃分析

2025-12-020
OAAI
Efficacy and Safety of FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

FOLFOXIRI联合西妥昔单抗与FOLFOXIRI联合贝伐珠单抗治疗转移性结直肠癌的疗效与安全性:一项系统评价和Meta分析

2025-10-010
PRE
Neoadjuvant FOLFIRINOX vs Gemcitabine Plus Paclitaxel for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis of Surgical and Pathological Outcomes

新辅助FOLFIRINOX与吉西他滨联合紫杉醇治疗 borderline resectable 和局部晚期胰腺癌:手术和病理结局的系统评价与Meta分析

2025-10-010
PRE
Is it necessary to stop glucagon-like peptide-1 receptor agonists prior to endoscopic procedure? A retrospective study

内镜检查前是否需要停用胰高血糖素样肽-1受体激动剂?一项回顾性研究

2024-07-144
OAAI